Reuters logo
BRIEF-Biophytis filed IND application for approval by FDA of Sara-Interest Phase 2b study of Sarconeos in sarcopenia
September 25, 2017 / 6:49 AM / 3 months ago

BRIEF-Biophytis filed IND application for approval by FDA of Sara-Interest Phase 2b study of Sarconeos in sarcopenia

Sept 25 (Reuters) - BIOPHYTIS SA:

* BIOPHYTIS FILED IND APPLICATION FOR APPROVAL BY FDA OF SARA-INTEREST PHASE 2B STUDY OF SARCONEOS IN SARCOPENIA

* FILING IN EUROPE WILL BE DONE IN THE COMING DAYS‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below